THC - Tenet Healthcare Corporation
NYSE
->
Healthcare
->
Medical Care Facilities
Dallas,
United States
Type: Equity
THC price evolution
THC
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1228 | $1054 | $934 | $766 |
| Short term investments | ||||
| Net receivables | $2914 | $2897 | $2914 | $2883 |
| Inventory | $411 | $413 | $404 | $407 |
| Total current assets | $7167 | $6359 | $5995 | $5869 |
| Long term investments | $3157 | $3152 | $3130 | $3175 |
| Property, plant & equipment | $6236 | $6260 | $6268 | $6319 |
| Goodwill & intangible assets | $11675 | $11815 | $11756 | $11690 |
| Total noncurrent assets | $21145 | $21231 | $21162 | $21198 |
| Total investments | $3157 | $3152 | $3130 | $3175 |
| Total assets | $28312 | $27590 | $27157 | $27067 |
| Current liabilities | ||||
| Accounts payable | $1408 | $1202 | $1246 | $1192 |
| Deferred revenue | $86 | $76 | $76 | |
| Short long term debt | $120 | $141 | $141 | $148 |
| Total current liabilities | $4760 | $4432 | $4152 | $4219 |
| Long term debt | $14882 | $14901 | $14907 | $14935 |
| Total noncurrent liabilities | $18044 | $17977 | $18004 | $18043 |
| Total debt | $15002 | $15042 | $15048 | $15083 |
| Total liabilities | $22804 | $22409 | $22156 | $22262 |
| Shareholders' equity | ||||
| Retained earnings | -$192 | -$436 | -$537 | -$660 |
| Other shareholder equity | -$181 | -$176 | -$178 | -$179 |
| Total shareholder equity | $1608 | $1464 | $1343 | $1233 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1228 | $858 | $2364 | $2446 |
| Short term investments | ||||
| Net receivables | $2914 | $2943 | $2770 | $2690 |
| Inventory | $411 | $405 | $384 | $368 |
| Total current assets | $7167 | $5981 | $7075 | $7147 |
| Long term investments | $3157 | $3147 | $3254 | $2534 |
| Property, plant & equipment | $6236 | $6462 | $6427 | $6692 |
| Goodwill & intangible assets | $11675 | $11547 | $10758 | $10408 |
| Total noncurrent assets | $21145 | $21175 | $20504 | $19959 |
| Total investments | $3157 | $3147 | $3254 | $2534 |
| Total assets | $28312 | $27156 | $27579 | $27106 |
| Current liabilities | ||||
| Accounts payable | $1408 | $1504 | $1300 | $1207 |
| Deferred revenue | $110 | $959 | $659 | |
| Short long term debt | $120 | $145 | $135 | $145 |
| Total current liabilities | $4760 | $4476 | $5109 | $4847 |
| Long term debt | $14882 | $14934 | $15511 | $15574 |
| Total noncurrent liabilities | $18044 | $18072 | $18213 | $19370 |
| Total debt | $15002 | $15079 | $15646 | $15719 |
| Total liabilities | $22804 | $26014 | $23322 | $24217 |
| Shareholders' equity | ||||
| Retained earnings | -$192 | -$803 | -$1214 | -$2128 |
| Other shareholder equity | -$181 | -$181 | -$233 | -$281 |
| Total shareholder equity | $1608 | $1142 | $1028 | $28 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5381 | $5069 | $5090 | $5024 |
| Cost of revenue | ||||
| Gross Profit | $5381 | $5069 | $5090 | $5024 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $2315 | $2288 | $2285 | $2258 |
| Total operating expenses | $4719 | $4552 | $4540 | $4471 |
| Operating income | $662 | $517 | $550 | $553 |
| Income from continuing operations | ||||
| EBIT | $534 | $407 | $429 | $448 |
| Income tax expense | $63 | $79 | $80 | $84 |
| Interest expense | $227 | $227 | $226 | $221 |
| Net income | ||||
| Net income | $244 | $101 | $123 | $143 |
| Income (for common shares) | $244 | $101 | $123 | $143 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $20564 | $19368 | $19676 | $18522 |
| Cost of revenue | ||||
| Gross Profit | $20564 | $19368 | $19676 | $18522 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $9146 | $8844 | $8878 | $8418 |
| Total operating expenses | $18282 | $17251 | $17023 | $16702 |
| Operating income | $2282 | $2117 | $2653 | $1820 |
| Income from continuing operations | ||||
| EBIT | $1818 | $1645 | $2248 | $1305 |
| Income tax expense | $306 | $344 | $411 | -$97 |
| Interest expense | $901 | $890 | $923 | $1003 |
| Net income | ||||
| Net income | $611 | $411 | $914 | $399 |
| Income (for common shares) | $611 | $411 | $914 | $399 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $244 | $101 | $123 | $143 |
| Operating activities | ||||
| Depreciation | $216 | $224 | $213 | $217 |
| Business acquisitions & disposals | -$114 | -$14 | -$48 | -$48 |
| Stock-based compensation | $18 | $15 | $19 | $14 |
| Total cash flows from operations | $824 | $503 | $598 | $449 |
| Investing activities | ||||
| Capital expenditures | -$175 | -$154 | -$129 | -$222 |
| Investments | -$40 | -$3 | -$2 | -$9 |
| Total cash flows from investing | -$333 | -$169 | -$181 | -$286 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$110 | -$40 | -$50 | |
| Net borrowings | -$62 | -$36 | -$57 | -$33 |
| Total cash flows from financing | -$317 | -$214 | -$249 | -$255 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $174 | $120 | $168 | -$92 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $611 | $411 | $914 | $399 |
| Operating activities | ||||
| Depreciation | $870 | $841 | $855 | $857 |
| Business acquisitions & disposals | -$224 | -$234 | -$1220 | -$1177 |
| Stock-based compensation | $66 | $56 | $56 | $44 |
| Total cash flows from operations | $2374 | $1083 | $1568 | $3407 |
| Investing activities | ||||
| Capital expenditures | -$680 | -$552 | $590 | -$463 |
| Investments | -$54 | -$16 | -$77 | $15 |
| Total cash flows from investing | -$969 | -$808 | -$714 | -$1608 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$200 | -$250 | $23 | |
| Net borrowings | -$188 | -$852 | -$380 | $477 |
| Total cash flows from financing | -$1035 | -$1781 | -$936 | $385 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $370 | -$1506 | -$82 | $2184 |
News
Fundamentals
| Market cap | $9.94B |
|---|---|
| Enterprise value | $23.71B |
| Shares outstanding | 101.55M |
| Revenue | $20.56B |
|---|---|
| EBITDA | $2.69B |
| EBIT | $1.82B |
| Net Income | $611.00M |
| Revenue Q/Q | 6.98% |
| Revenue Y/Y | 6.99% |
| P/E ratio | 16.26 |
|---|---|
| EV/Sales | 1.15 |
| EV/EBITDA | 8.82 |
| EV/EBIT | 13.04 |
| P/S ratio | 0.48 |
| P/B ratio | 5.55 |
| Book/Share | 17.62 |
| Cash/Share | 12.09 |
| EPS | $6.02 |
|---|---|
| ROA | 2.22% |
| ROE | 43.27% |
| Debt/Equity | 14.18 |
|---|---|
| Net debt/EBITDA | 8.03 |
| Current ratio | 1.51 |
| Quick ratio | 1.42 |